961.14(2)(rg) (rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
961.14(2)(rj) (rj) 3-methylthiofentanyl (N-{3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(rm) (rm) Noracymethadol;
961.14(2)(s) (s) Norlevorphanol;
961.14(2)(sm) (sm) Normethadone;
961.14(2)(t) (t) Norpipanone;
961.14(2)(tg) (tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
961.14(2)(tm) (tm) Phenadoxone;
961.14(2)(u) (u) Phenampromide;
961.14(2)(um) (um) Phenomorphan;
961.14(2)(v) (v) Phenoperidine;
961.14(2)(vg) (vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
961.14(2)(vm) (vm) Piritramide;
961.14(2)(w) (w) Proheptazine;
961.14(2)(wm) (wm) Properidine;
961.14(2)(wn) (wn) Propiram;
961.14(2)(x) (x) Racemoramide;
961.14(2)(xm) (xm) Thiofentanyl (N-{1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);
961.14(2)(xr) (xr) Tilidine;
961.14(2)(y) (y) Trimeperidine.
961.14(3) (3)Substances derived from opium. Any material, compound, mixture or preparation which contains any quantity of any of the following substances derived from opium, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(3)(a) (a) Acetorphine;
961.14(3)(b) (b) Acetyldihydrocodeine;
961.14(3)(c) (c) Benzylmorphine;
961.14(3)(d) (d) Codeine methylbromide;
961.14(3)(e) (e) Codeine-N-oxide;
961.14(3)(f) (f) Cyprenorphine;
961.14(3)(g) (g) Desomorphine;
961.14(3)(h) (h) Dihydromorphine;
961.14(3)(hm) (hm) Drotebanol;
961.14(3)(j) (j) Etorphine, except its hydrochloride salts;
961.14(3)(k) (k) Heroin;
961.14(3)(m) (m) Hydromorphinol;
961.14(3)(n) (n) Methyldesorphine;
961.14(3)(p) (p) Methyldihydromorphine;
961.14(3)(q) (q) Morphine methylbromide;
961.14(3)(r) (r) Morphine methylsulfonate;
961.14(3)(s) (s) Morphine-N-oxide;
961.14(3)(t) (t) Myrophine;
961.14(3)(u) (u) Nicocodeine;
961.14(3)(v) (v) Nicomorphine;
961.14(3)(w) (w) Normorphine;
961.14(3)(x) (x) Pholcodine;
961.14(3)(y) (y) Thebacon.
961.14(4) (4)Hallucinogenic substances. Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers, precursors, analogs, esters, ethers, and salts of isomers, esters, or ethers that are theoretically possible within the specific chemical designation, in any form contained in a plant, obtained from a plant, or chemically synthesized:
961.14(4)(a) (a) 3,4-methylenedioxyamphetamine, commonly known as "MDA";
961.14(4)(ag) (ag) 3,4-methylenedioxyethylamphetamine, commonly known as "MDE";
961.14(4)(am) (am) 3,4-methylenedioxymethamphetamine, commonly known as "MDMA";
961.14(4)(ar) (ar) N-hydroxy-3,4-methylenedioxyamphetamine;
961.14(4)(b) (b) 5-methoxy-3,4-methylenedioxyamphetamine;
961.14(4)(bm) (bm) 4-ethyl-2,5-dimethoxyamphetamine, commonly known as "DOET";
961.14(4)(c) (c) 3,4,5-trimethoxyamphetamine;
961.14(4)(cm) (cm) Alpha-ethyltryptamine;
961.14(4)(d) (d) Bufotenine;
961.14(4)(e) (e) Diethyltryptamine;
961.14(4)(f) (f) Dimethyltryptamine;
961.14(4)(g) (g) 4-methyl-2,5-dimethoxyamphetamine, commonly known as "STP";
961.14(4)(h) (h) Ibogaine;
961.14(4)(j) (j) Lysergic acid diethylamide, commonly known as "LSD";
961.14(4)(m) (m) Mescaline, in any form, including mescaline contained in peyote, obtained from peyote or chemically synthesized;
961.14(4)(mn) (mn) Parahexyl (3-hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo(b, d)pyran);
961.14(4)(n) (n) Phencyclidine, commonly known as "PCP";
961.14(4)(p) (p) N-ethyl-3-piperidyl benzilate;
961.14(4)(q) (q) N-methyl-3-piperidyl benzilate;
961.14(4)(r) (r) Psilocybin;
961.14(4)(s) (s) Psilocin;
961.14(4)(t) (t) Tetrahydrocannabinols, commonly known as "THC", in any form including tetrahydrocannabinols contained in marijuana, obtained from marijuana or chemically synthesized;
961.14(4)(tb) (tb) Cannabicyclohexonal: 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol.
961.14(4)(te) (te) CP47,497 and homologues: 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol.
961.14(4)(th) (th) HU-210: [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10, 10a-tetrahydrobenzo[c]chromen-1-o1)], also known as (6aR,10aR)-3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-
dimethyl-6H-dibenzo[b,d]pyran-9-methanol.
961.14(4)(tL) (tL) JWH-018: 1-pentyl-3-(1-naphthoyl)indole, also known as Naphthalen-1-yl-(1-pentylindol-3-yl)methanone.
961.14(4)(tp) (tp) JWH-073): 1-butyl-3-(1-naphthoyl)indole, also known as Naphthalen-1-yl-(1-butylindol-3-yl)methanone.
961.14(4)(tr) (tr) JWH-081: 1-pentyl-3-(4-methoxy-1-naphthoyl)indole, also known as 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone.
961.14(4)(tu) (tu) JWH-200: 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole.
961.14(4)(ty) (ty) JWH-250: 1-pentyl-3-(2-methoxyphenylacetyl)indole, also known as 2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone.
961.14(4)(u) (u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
961.14(4)(ud) (ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
961.14(4)(ug) (ug) N-ethyl-1-phenylcyclohexylamine, which is the ethylamine analog of phencyclidine;
961.14(4)(ur) (ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
961.14(4)(v) (v) 2,5-dimethoxyamphetamine;
961.14(4)(w) (w) 4-bromo-2,5-dimethoxyamphetamine, commonly known as "DOB";
961.14(4)(wg) (wg) 4-bromo-2,5-dimethoxy-beta-phenylethylamine, commonly known as "2C-B" or "Nexus";
961.14(4)(wgm) (wgm) 4-iodo-2,5-dimethoxy-beta-phenylethylamine, commonly known as "2C-I".
961.14(4)(wh) (wh) 2,5 dimethoxy-4-(n)-propylthiophenethylamine, commonly known as "2C-T-7";
961.14(4)(wi) (wi) Alpha-methyltryptamine, commonly known as "AMT";
961.14(4)(wj) (wj) 5-methoxy-N, N-diisopropyltryptamine, commonly known as "5-MeO-DIPT";
961.14(4)(x) (x) 4-methoxyamphetamine, commonly known as "PMA."
961.14(5) (5)Depressants. Any material, compound, mixture or preparation which contains any quantity of any of the following substances having a depressant effect on the central nervous system, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
961.14(5)(ag) (ag) Gamma-hydroxybutyric acid (commonly known as gamma hydroxybutyrate or "GHB"), gamma-butyrolactone, and 1,4-butanediol.
Loading...
Loading...
This is an archival version of the Wis. Stats. database for 2011. See Are the Statutes on this Website Official?